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Abstract
Objectives: Magnetic resonance imaging (MRI) is not
accurate in discriminating T1-2 from borderline T3 rectal
tumors. Higher resolution on 3 Tesla-(3T)-MRI could
improve diagnostic performance for T-staging. The aim
of this study was to determine whether 3T-MRI com-
pared with 1.5 Tesla-(1.5T)-MRI improves the accuracy
for the discrimination between T1-2 and borderline T3
rectal tumors and to evaluate reproducibility.
Methods: 13 patients with non-locally advanced rectal
cancer underwent imaging with both 1.5T and 3T-MRI.
Three readers with different expertise evaluated the
images and predicted T-stage with a confidence level
score. Receiver operator characteristics curves with areas
under the curve (AUC) and diagnostic parameters were
calculated. Inter- and intra-observer agreements were
calculated with quadratic kappa-weighting. Histology
was the reference standard.
Results: Seven patients had pT1-2 tumors and six had
pT3 tumors. AUCs ranged from 0.66 to 0.87 at 1.5T vs.
0.52–0.82 at 3T. Mean overstaging rate was 43% at 1.5T
and 57% at 3T (P = 0.23). Inter-observer agreement was
j 0.50–0.71 at 1.5T vs. 0.15–0.68 at 3T. Intra-observer
agreement was j 0.71 at 1.5T and 0.76 at 3T.
Conclusions: This is the first study to compare 3T with
1.5T MRI for T-staging of rectal cancer within the same
patients. Our results showed no difference between 3T
and 1.5T-MRI for the distinction between T1-2 and
borderline T3 tumors, regardless of expertise. The higher
resolution at 3T-MRI did not aid in the distinction
between desmoplasia in T1-2-tumors and tumor strand-
ing in T3-tumors. Larger studies are needed to acknowl-
edge these findings.
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Besides surgery, neoadjuvant treatment with chemo-
and/or radiotherapy has become a crucial part of the
treatment of rectal cancer. The choice of the type of
neoadjuvant treatment and surgery is based on preop-
erative imaging. During the past decade magnetic reso-
nance imaging (MRI) has been proven to be the most
accurate staging modality for primary rectal cancer [1].
With preoperative imaging the T-stage, involved cir-
cumferential resection margin (CRM), nodal involve-
ment, and location of the tumor are evaluated, which
determine the type of (pre)operative treatment. So far,
MRI has not been able to accurately predict T-stage
unless an endorectal coil is used [2, 3]. However, an
endoluminal technique leads to less visibility of sur-
rounding structures in the mesorectum because of the
limited field of view. Furthermore, it is difficult to apply
this technique in high and stenosing tumors. Therefore,
endorectal MRI has been less adopted for staging small
rectal tumors than endorectal ultrasound (EUS) [4, 5].
EUS has equally good accuracy as endorectal MRI for
identification of T1 tumors, is less cumbersome and is
therefore the exam of choice for staging superficial rectal
cancer [6]. It is, however, less accurate for staging of the
more advanced tumors, in specific those with threatened
CRM because EUS cannot identify the mesorectal fascia.
Therefore, MRI with phased-array coils is widely adop- Correspondence to: Regina G. H. Beets-Tan; email: beetstan@me.com
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bulky T3 and T4 tumors with sensitivities ranging from
74% to 94% and specificities from 74% to 76% [7]. It is
the borderline tumor, the T2 or small T3 tumor, that
remains a diagnostic challenge. The distinction between
T2 and borderline T3 tumors has important implications
for clinical decision making. When a tumor is confined to
the bowel wall (T1-2) the patient will undergo surgery
immediately without neoadjuvant treatment, but when
the tumor penetrates the bowel wall (T3) the current
trend is to administer preoperative neoadjuvant therapy
(radiotherapy with or without chemotherapy) prior to
surgery. Furthermore, when a tumor is confined to the
bowel wall local excision—leading to less morbidity and
mortality than with standard surgery—could be consid-
ered [8], whereas in tumors outgrowing the bowel wall
this is not possible. A large proportion of the pT2 tumors
is overstaged, because desmoplastic benign reactions are
mistaken for tumoral extensions associated with a bor-
derline pT3 tumor [9]. Overstaging would thus lead to
overtreatment of patients with T1-2 tumors, with in-
creased risk for treatment related morbidity and mor-
tality.
Most studies evaluating the accuracy of phased-array
MRI for rectal cancer staging have focused on 1.5 Tesla
(1.5T) MR units. MR imaging at higher ﬁeld strength
(3 Tesla) could improve the diagnostic performance of
phased-array MRI for T-stage prediction. Three Tesla
(3T) MRI has a theoretical two-fold increase of signal-
to-noise ratio compared to 1.5T MRI [10]. This could
allow for better resolution and enhanced image quality,
resulting in a more accurate distinction between T2 and
borderline T3 tumors. Only few studies exist on 3T MRI
for T-stage prediction in rectal cancer. To the best of our
knowledge, no report exists on the intra-patient com-
parison of the diagnostic performance of 3T MRI with
that of 1.5T MRI [9, 11–16].
Therefore, the aim of this study is to determine, with
an intra-patient comparison, whether 3T MRI compared
with 1.5T MRI leads to improvement of accuracy for the
differentiation between tumors conﬁned to the bowel
wall (T1-2) and tumors penetrating the bowel wall (T3)
and to evaluate reproducibility.
Materials and methods
Patients
Between November 2007 and July 2008, 13 patients with
primary non-locally advanced rectal cancer who under-
went MR imaging of the pelvis at 1.5 and 3T (with a
mean interval of 19.8 ± 10.8 days) were included. The
3T MRI scans were performed as part of another MRI
study protocol, which was approved by the local insti-
tutional review board. Inclusion criteria were: (1) pa-
tients had to have undergone pelvic MRI at 1.5 and 3T,
(2) had non-locally advanced rectal cancer and under-
went 5 9 5 Gray followed by immediate surgery, which
has been shown to have no downstaging effect on the
tumor [17]. Non-locally advanced rectal cancer was de-
fined as tumors with a T-stage up to borderline T3 and
uninvolved CRM, based on histology after surgery,
which was the reference standard.
MRI techniques
Patients were placed in feet ﬁrst supine position. No
antiperistaltic agent or endorectal ﬁlling was adminis-
tered prior to imaging. Phased-array multichannel coils
were used for signal reception. The 1.5T MR unit was
either an Intera unit (n = 5, Philips Medical Systems,
Best, The Netherlands) or an Avanto unit (n = 8, Sie-
mens Medical Solutions, Erlangen, Germany). The MR
sequences followed the standard rectal MR protocol as
described in the literature and consisted of 2D T2-
weighted fast spin echo (FSE) sequences (TR/TE 3500-
4780/94-150 ms, with in plane resolution ranging from
1.14 9 0.78 to 1.09 9 1.56 mm
2, slice thickness 3–5 mm)
in two planes: sagittal and axial. Acquisition time per
sequence ranged from 3:17 to 5:08 min. All patients
underwent a second scan at a 3T MRI unit (Intera
Achieva (software release 1.5.4.0); Philips Medical Sys-
tems, Best, The Netherlands) with standard 2D T2-
weighted FSE sequences (TR/TE 3107/150 ms, in plane
resolution 0.65 9 1.06 mm
2, slice thickness 4 mm) in two
planes: sagittal and axial. Acquisition time per sequence
was 2:52 min. This sequence was based partially on the
sequence as published in the literature by Kim et al. [14].
Image analysis
Three readers with different experience in reading rectal
cancer MRI retrospectively evaluated the images, inde-
pendently and blinded for each other’s and histological
results. Image evaluation was performed according to
earlier published criteria [18, 19]. Reader 1 has 7 years of
specific experience in reading rectal MR in a referral
hospital. Reader 2 is an experienced MR rectum reader
who has 5 years of experience in a referral hospital.
Reader 3 is a general radiologist who works in a general
hospital, without specific MR rectum experience.
All readers evaluated the MR images for the T-stage
as follows: the likelihood for tumor conﬁned to the bowel
wall (T1-2) was scored using a conﬁdence level system
ranging from: 0 = deﬁnitely outgrowing wall,
1 = probably outgrowing wall, 2 = possibly conﬁned
to the wall, 3 = probably conﬁned to wall, and
4 = deﬁnitely conﬁned to wall. All readers evaluated the
images at the same Picture Archiving and Communica-
tion System.
All readers evaluated the 1.5T scans ﬁrst. After a
30 min interval, the 3T images were evaluated at random
patient order, besides blinding for each others’ and his-
476 M. Maas et al.: 3T vs. 1.5T MRI in rectal cancertology results, the readers were also blinded for the 1.5T
results. These evaluations were used for analysis and
comparison of the accuracy between 1.5 and 3T MRI for
T-stage prediction.
Furthermore, for reader 2 an additional scoring
procedure of both 1.5 and 3T scans was organized to
determine intra-observer agreement (with an interval of
2 weeks between scoring procedures).
Histopathologic examination
Results for T-stage prediction by all readers at both ﬁeld
strengths were compared with histopathological staging
of the surgical specimen, which was the reference stan-
dard. Surgery was performed directly subsequent to the
short course of radiation. The surgical specimens were
handled according to standard clinical practice as
advocated by Quirke et al. [20] and were pathologically
examined in accordance with the Tumor Node Metas-
tasis staging system.
Statistical analysis
For statistical analyses Statistical Package for the So-
cial Sciences (SPSS, version 15, Inc., Chicago, IL) was
used. Receiver operator characteristics (ROC) curve
analyses were performed and areas under the curve
(AUC) with 95% conﬁdence intervals (CI) were cal-
culated. AUCs were compared according to the
method as described by DeLong [21] using Stata
software (Stata, release 9.2; StataCorp, College Station,
Texas) to determine whether the difference in diag-
nostic performance between both field strengths was
statistically significant. Sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV) with 95%CI were calculated for all readers on
both field strengths. For these analyses, it was decided
at the start of the study to use a cut-off level between
confidence level 2 (possibly confined to the bowel wall)
and 3 (probably confined to the bowel wall), with tu-
mor confined to the bowel wall as the positive out-
come measure. Mean overstaging rate of tumors
limited to the bowel wall and understaging rate of
tumors outgrowing the bowel wall were calculated for
all the three readers. The paired samples t test was
used to test whether the difference in mean over- and
understaging rates between 1.5T MRI and 3T MRI
was statistically significant. Intra- and inter-observer
agreements were analyzed by using weighted kappa
values with quadratic weighting. Degree of agreement
was stated as follows: j value 0.00–0.20 poor agree-
ment; j value 0.21–0.40 fair agreement; j value 0.41–
0.60 moderate agreement; j value 0.61–0.80 good
agreement, and j value 0.81–1.00 excellent agreement.
P values smaller than 0.05 were considered statistically
significant.
Results
Patient characteristics
Median age of the 13 included patients was 67 years
(range 53–78), 10 were male and 3 were female. Of the 13
patients, 3 had pT1 tumors, 4 had pT2 tumors, and 6 had
pT3 tumors, thus 7 patients had tumor conﬁned to the
bowel wall (pT1-2) and 6 had tumor outgrowing the
bowel wall (pT3). Total mesorectal excision was per-
formed in all 13 patients. Median interval between ﬁnal
radiation dose and surgery was 1 day (range 1–5).
Diagnostic performance
Sensitivity, speciﬁcity, PPV, NPV, AUC, overstaging,
and understaging rates for all readers at both ﬁeld
strengths are shown in Table 1. ROC curves for all
readers at both field strengths are shown in Figure 1.
There was no difference in AUC for 1.5 and 3T between
the readers except between reader 1 (0.821) and reader 3
(0.524) at 3T MRI (P = 0.04).
Mean rates of overstaging and understaging for all
readers were comparable at both ﬁeld strengths (Fig. 2).
Mean overstaging was 43% at 1.5T vs. 57% at 3T
(P = 0.23). Mean understaging was 11% at 1.5T vs. 17%
at 3.0T (P = 0.42).
Agreement
At 1.5T, inter-observer agreement was moderate to good
(j 0.502–0.708). Inter-observer agreement was lower at
3T MRI (j 0.153–0.681). Intra-observer agreement
(reader 2) was good: at 1.5T weighted j was 0.710 (95%
CI: 0.544–0.875) and at 3T weighted j was 0.762 (95%
CI: 0.662–0.862). Results for agreement are presented in
Table 2.
Discussion
This intra-patient comparison study between 3 and 1.5T
MRI does not show an improved diagnostic performance
for T-staging with 3T MRI regardless of the experience
of the reader, with sensitivities from 29% to 57% and
speciﬁcities from 50% to 83%. For the reader from a
general hospital, prediction at 3T MRI was least accu-
rate. Overstaging was higher at 3T MRI and highest for
the general reader: 86% at 3T compared to 57% at 1.5T.
Inter-observer agreement was moderate to good at 1.5T
and poor to good at 3T MRI. Intra-observer agreement
was measured for reader 2 and was good.
Our ﬁnding that 3T is not better than 1.5T MRI for
T2 vs. T3 differentiation might be surprising; neverthe-
less, it could be explained given the fact that with MR the
differentiation between T1-2 and T3 tumors is associated
with interpretation difﬁculties in the distinction between
desmoplastic benign reactions in a T2 tumor and
M. Maas et al.: 3T vs. 1.5T MRI in rectal cancer 477malignant tumor stranding in a T3 tumor (Fig. 3). This
results in substantial overstaging errors in this group of
borderline tumors, confirming the findings of other
Fig. 2. Mean over- and understaging rates for 1.5 and 3T
MRI.
Fig. 1. ROC curves for T-stage prediction for all readers at 3
and 1.5T.
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Table 2. Inter-observer and intra-observer agreement
j
1.5 Tesla MRI 3 Tesla MRI
Inter-observer
Reader 2 vs. reader 1 0.544 (0.132–0.956) 0.301 (0–0.744)
Reader 2 vs. reader 3 0.708 (0.458–0.958) 0.681 (0.408–0.953)
Reader 1 vs. reader 3 0.502 (0.057–0.947) 0.153 (0–0.587)
Intra-observer
Reader 2 0.710 (0.544–0.875) 0.762 (0.662–0.862)
478 M. Maas et al.: 3T vs. 1.5T MRI in rectal cancerauthors [18, 22]. Overstaging rates at 1.5T MRI are re-
ported to range from 25% to 46% [9]. In our study at
1.5T, overstaging occurred in 29%–57%, slightly higher
figures than in the literature because of our study pop-
ulation, with mainly patients with borderline T1-2 and
T3 tumors. At 3T, it was higher ranging from 43% to
86%. This confirms the hypothesis that despite the
inherent higher resolution and the more detailed depic-
tion of the rectal wall, 3T does not help us to obtain a
better performance because the interpretation difficulties
of desmoplastic reactions with or without tumor cells
remain.
Our results are in contrast to other publications. Only
small studies on 3T MRI have been reported and these
showed controversial ﬁndings with overstaging rates
ranging from 15% to 30% [11]. In the largest study to
date by Kim et al. [13] in 109 patients who were evalu-
ated at 3T MRI, only equal overstaging rates were found
as earlier reported with 1.5T MRI. Their findings suggest
that 3T MRI is, unlike our results, not worse than 1.5T
MRI.
The inter-observer agreement was lower at 3T MRI
compared to 1.5T MRI, which indicates higher degrees
of uncertainty between readers. This may have been
caused by the more detailed depiction of the tumor and
of the normal anatomy. Improved visibility at 3T MRI
of small vessels penetrating the rectal wall may cause
more interpretation difﬁculties (Fig. 4A, B). Increased
variation between readers just by chance would be less
likely because of the relatively high intra-observer
agreement at both field strengths, although tested in only
one of the readers (reader 2). We believe that the solid
intra-observer agreement at both field strengths can be
explained by the type of case mix that reader 2 is exposed
to in the referral hospital, which had resulted in a stable
and consistent learning curve, making him more flexible
to handle different and new techniques.
The highest overstaging rate was found in the
reader from a non referral center (86% at 3T). The fact
that this reader reads rectal MRI on a less frequent
basis than the others might explain the inferior results
compared to the others. This trend may be even
aggravated by the more detailed depiction at 3T MRI
which can lead to more interpretation difﬁculties in the
less experienced reader in particular. The PPV for
staging of T2 tumors with MRI is known to be high
[23], because the existence of a hypo-intense bowel wall
on T2W FSE sequences (Fig. 5) is a reliable predictive
criterion for a tumor limited to the bowel wall. Yet
this sign is subject to some learning curve. Therefore,
readers from a referral center are more confident to
identify a tumor that is restricted to the bowel wall
based on this bowel wall sign.
There are some limitations to this study. First, the
sample size is small. Nevertheless, this is the ﬁrst study
performing an intra-patient comparison between 1.5
and 3T. Thus, the results are important and suggest
that it is not so obvious that 3T MRI would be better
than 1.5T MRI. Second, it can be argued that other
published studies had a higher resolution at 3T than
our study [11, 13–15]. Furthermore, it would have been
ideal to have a similar acquisition time at 3T as at
1.5T. We acknowledge that our 3T protocol could be
improved; however, due to the retrospective nature of
the study this was not possible. Nevertheless, compared
to our 1.5T standard rectal MR protocol, our 3T
protocol was still superior in resolution and we could
not achieve better results with 3T MRI. Third, we
performed the 1.5T scans on two different MR units
and the 3T scans on one unit. If this would have
influenced our findings, we would expect an advantage
for the diagnostic performance of 3T MRI (because of
a uniform image acquisition at 3T for all patients),
which we did not find in this study.
Fig. 3. Stranding (arrows) around a pT2 tumor which cannot be distinguished from tumor extension in a T3 tumor (left 1.5T and
right 3T).
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Accurate staging of tumors limited to the bowel wall vs.
tumors outgrowing the rectal wall is important because it
determines treatment stratiﬁcation. When tumors are
conﬁned to the bowel wall (T1-2), patients are referred
for immediate TME. When the tumor penetrates the
bowel wall (T3-4), the patient will be stratiﬁed for a more
intensive treatment arm with a long course of chemora-
diation treatment followed by resection. In the Nether-
lands and Northern Europe, patients with T3 tumors
without CRM involvement are given preoperative 5 9 5
Gray radiation treatment (instead of a long course of
chemoradiation) followed by immediate TME. Over-
staging of T2 tumors by MRI would lead to a substantial
overtreatment of patients with a T1-2 tumor, who will
receive unnecessary preoperative (chemo)radiotherapy.
Furthermore, the recent trend toward organ sparing
treatment propagates local excision for tumors that are
limited to the bowel wall [8]. When local excision be-
comes standard treatment for T1-2 tumors, the high
overstaging rate leads to overtreatment of these patients
as well, with not only unnecessary neoadjuvant treat-
ment, but also an unnecessary TME.
Conclusions
In this ﬁrst intra-patient comparison between 3T MRI
with 1.5T MRI for the clinically relevant distinction be-
tween T2 and borderline T3 tumors, no improvement
was found with 3T MRI, regardless of the expertise of
the readers. Even though there is a better visibility of the
rectal wall at 3T, it does not aid in the distinction be-
tween T2 tumors with desmoplasia and borderline T3
tumors with tumor stranding in the mesorectal fat, a
distinction which is crucial for the differentiation and
known to be difﬁcult on MRI. The lower inter-observer
agreement at 3T MRI reﬂects less certainty about the
prediction of the T-stage, most prominent in the reader
from a general hospital. Future studies have to validate
these ﬁndings in a larger sample size by comparing local
staging of rectal cancer at 3T with 1.5T MRI in one
patient group.
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